Proteonomix, Inc.
PROT · OTC
12/31/2011 | 12/31/2010 | 12/31/2009 | 12/31/2008 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -68.8% | -41.2% | 7.3% | – |
| Cost of Goods Sold | -$0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 102% | 81% | 83.6% | 86.7% |
| R&D Expenses | $1 | $0 | $0 | $0 |
| G&A Expenses | $1 | $3 | $4 | $5 |
| SG&A Expenses | $1 | $3 | $4 | $5 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | -$0 | $0 |
| Operating Expenses | $1 | $4 | $4 | $5 |
| Operating Income | -$1 | -$3 | -$4 | -$5 |
| % Margin | -5,026.1% | -4,140.6% | -2,696.1% | -3,677.7% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$1 | -$3 | -$4 | -$5 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1 | -$3 | -$4 | -$5 |
| % Margin | -5,322.3% | -4,164.6% | -2,723.7% | -3,763.3% |
| EPS | -0.21 | -0.75 | -1.16 | -2.33 |
| % Growth | 72% | 35.3% | 50.2% | – |
| EPS Diluted | -0.21 | -0.75 | -1.16 | -2.33 |
| Weighted Avg Shares Out | 7 | 5 | 3 | 2 |
| Weighted Avg Shares Out Dil | 7 | 5 | 3 | 2 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$3 | -$4 | -$5 |
| % Margin | -3,576.4% | -3,846.6% | -2,686.3% | -3,594.4% |